App-Quantinova.ai

Aldo-keto reductase (AKR) 1C1 – a potential driver of cell cycle progression in hepatocellular carcinoma

Ismael da Conceiao - European Congress of Endocrinology (ECE) , 2020

Therapeutic Area

Disease

Drug/Treatment

Gastroenterology (GU)

Nonalcoholic fatty liver disease

Hydroxyprogesterone caproate

Management and outcomes of graves’ disease – a retrospective audit

Elaine Soong - European Congress of Endocrinology (ECE) , 2020

Therapeutic Area

Disease

Drug/Treatment

Endocrine/metabolic Diseases (ME)

Hyperthyroidism

N/A

Challenges in the management of pituitary involvement in granulomatosis with Polyangitis (GPA): 2 cases managed at Imperial college healthcare trust

Preeshila Behary - European Congress of Endocrinology (ECE) , 2020

Therapeutic Area

Disease

Drug/Treatment

Endocrine/metabolic Diseases (ME)

Hypogonadotropic hypogonadism

Cyclophosphamide

Challenges in management and pharmacotherapeutic strategy in patients with a prolactinoma and neuropsychosis; a case presentation and literature review

Ahmad Moolla - European Congress of Endocrinology (ECE) , 2020

Therapeutic Area

Disease

Drug/Treatment

Central Nervous System (CNS)

Hyperprolactinemia

Aripiprazole

Free 25-hydroxyvitamin D, but not free 1.25-dihydroxyvitamin D, predicts all-cause mortality in ageing men

Leen Antonio - European Congress of Endocrinology (ECE) , 2020

Therapeutic Area

Disease

Drug/Treatment

N/A

Ergocalciferol

Modified GRAS score for prognostic classification of adrenocortical carcinoma: an ENSAT multicentre study

Yasir Elhassan - European Congress of Endocrinology (ECE) , 2020

Therapeutic Area

Disease

Drug/Treatment

Oncology (ONC)

Adrenal carcinoma

N/A

Very low HbA1c– a case presentation

Bethany Woodrow - European Congress of Endocrinology (ECE) , 2020

Therapeutic Area

Disease

Drug/Treatment

Endocrine/metabolic Diseases (ME)

Thrombocytopenia

Atorvastatin

Female AKR1D1 knockout mice have impaired intestinal health with evidence of gut dybiosis, increased gut permeability and an increased incidence of colon cancer

Anastasia Arvaniti - European Congress of Endocrinology (ECE) , 2020

Therapeutic Area

Disease

Drug/Treatment

Gastroenterology (GU)

Nonalcoholic fatty liver disease

Occlusal-HP Topical

Expression ofestrogen-related receptors andepidermal growth factor receptorin normal adrenal cortex and adrenocortical tumors: A possible role of GPR30 and EGFR in adrenocortical malignancy

Christos Parianos - European Congress of Endocrinology (ECE) , 2020

Therapeutic Area

Disease

Drug/Treatment

Oncology (ONC)

Adrenal carcinoma

N/A

Persistent hypokalaemia leading to a diagnosis carcinoid lung cancer. A case study

Benjamin Woolner - European Congress of Endocrinology (ECE) , 2020

Therapeutic Area

Disease

Drug/Treatment

Oncology (ONC)

Idiopathic pulmonary fibrosis

Dexamethasone

AKR1D1 regulates androgen availability in vitro by generating metabolites that are unable to activate the androgen receptor

Elena Gangitano - European Congress of Endocrinology (ECE) , 2020

Therapeutic Area

Disease

Drug/Treatment

N/A

Dihydrotestosterone

Clinical evidence of the cost effectiveness of bariatric surgery in management of type 2 diabetes mellitus and obesity to prevent associated co-morbidity

Mahamud Bashir - European Congress of Endocrinology (ECE) , 2020

Therapeutic Area

Disease

Drug/Treatment

Endocrine/metabolic Diseases (ME)

Type 2 diabetes mellitus

Finasteride

Role of endocrine specialist nurse in early inpatient discharge

Anna Hawkins - European Congress of Endocrinology (ECE) , 2020

Therapeutic Area

Disease

Drug/Treatment

Endocrine/metabolic Diseases (ME)

Diabetes

N/A

Not just another headache – a rare case of recurrent pituitary collection

Su Tee - European Congress of Endocrinology (ECE) , 2020

Therapeutic Area

Disease

Drug/Treatment

Endocrine/metabolic Diseases (ME)

Inflammatory bowel disease

Hydrocortisone

What we found the hidden cause of SIADH?

Yin Yin - European Congress of Endocrinology (ECE) , 2020

Therapeutic Area

Disease

Drug/Treatment

Endocrine/metabolic Diseases (ME)

Neuroendocrine tumors

Demeclocycline

The extent of variation in the reporting of clinical activity by reference centres in the field of rare pituitary and thyroid disorders within Endo-ERN, a new reference network for rare endocrine conditions in Europe

Friso de Vries - European Congress of Endocrinology (ECE) , 2020

Therapeutic Area

Disease

Drug/Treatment

N/A

Severe hypothyroidism secondary to Hashimoto’s thyroiditis and its implications for surgery

Xinming Yu - European Congress of Endocrinology (ECE) , 2020

Therapeutic Area

Disease

Drug/Treatment

Cardiovascular (CVS)

Subclinical hypothyroidism

Levothyroxine

Digital evaluation of ketosis and other diabetes emergencies (DEKODE) algorithm: Automated auditing system for diabetic ketoacidosis (DKA) management

Agnes Johnson - European Congress of Endocrinology (ECE) , 2020

Therapeutic Area

Disease

Drug/Treatment

Endocrine/metabolic Diseases (ME)

Diabetic ketoacidosis

N/A

Subclinical hypothyroidism and non-alcoholic fatty liver disease: A systematic review and meta-analysis

Yuli Guzman-Prado - European Congress of Endocrinology (ECE) , 2020

Therapeutic Area

Disease

Drug/Treatment

Gastroenterology (GU)

Nonalcoholic fatty liver disease

N/A

Mediterranean diet as a novel adjuvant treatment for type 1 diabetes

Alexis Kyriacou - European Congress of Endocrinology (ECE) , 2020

Therapeutic Area

Disease

Drug/Treatment

Endocrine/metabolic Diseases (ME)

Type 1 diabetes mellitus

N/A

Filters

45280 Abstracts